KTCCX
Price
$13.83
Change
-$0.38 (-2.67%)
Updated
Feb 21 closing price
Net Assets
1.87B
PRGTX
Price
$21.41
Change
-$0.57 (-2.59%)
Updated
Feb 21 closing price
Net Assets
4.7B
Ad is loading...

KTCCX vs PRGTX

Header iconKTCCX vs PRGTX Comparison
Open Charts KTCCX vs PRGTXBanner chart's image
DWS Science and Technology C
Price$13.83
Change-$0.38 (-2.67%)
VolumeN/A
Net Assets1.87B
T. Rowe Price Global Technology
Price$21.41
Change-$0.57 (-2.59%)
VolumeN/A
Net Assets4.7B
KTCCX vs PRGTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
KTCCX vs. PRGTX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KTCCX is a Hold and PRGTX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PRGTX has more cash in the bank: 4.7B vs. KTCCX (1.87B). KTCCX (0.00) and PRGTX (0.00) have matching dividends . KTCCX was incepted earlier than PRGTX: KTCCX (31 years) vs PRGTX (24 years). PRGTX is a more actively managed with annual turnover of: 53.90 vs. KTCCX (36.00). KTCCX has a lower initial minimum investment than PRGTX: KTCCX (1000) vs PRGTX (2500). PRGTX annual gain was more profitable for investors over the last year : 21.30 vs. KTCCX (-4.82). PRGTX return over 5 years is better than : 19.34 vs. KTCCX (-13.07).
KTCCXPRGTXKTCCX / PRGTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years24 years-
Gain YTD1.1702.63744%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.87B4.7B40%
Annual Yield % from dividends0.000.00-
Returns for 1 year-4.8221.30-23%
Returns for 3 years-10.2523.69-43%
Returns for 5 years-13.0719.34-68%
Returns for 10 years3.4463.065%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAPMF164.691.27
+0.77%
Capgemini SE
BZLFY21.18-0.06
-0.28%
Bunzl plc
KYCCF414.00-8.52
-2.02%
Keyence Corp.
PVCT0.11N/A
-2.62%
Provectus Biopharmaceuticals, Inc.
ATZAF46.74-1.33
-2.76%
Aritzia Inc.